Embryology and Fetal Development

Sites and Outcomes of Implantation

• Normal site: posterior wall of uterine body.

• Abnormal intra-uterine site ➔ implantation over the internal cervical os/cervical canal ≈ placenta praevia.

• Extra-uterine (ectopic) implantation most often in the ampulla or infundibulum of the fallopian tube.

Implantation Milestones (≈ $10-12$ days post-fertilisation)

• Inner cell mass → bilaminar embryonic disc.

• Trophoblast differentiates into:

  • Syncytiotrophoblast – erodes maternal tissues, forms maternal lacunae.

  • Cytotrophoblast – forms primary chorionic villi.

• Placenta, membranes and embryo begin developing simultaneously.

Embryonic Period Overview (weeks $3-8$)

• Transformation from bilaminar flat disc to embryo possessing all major organ systems & functioning cardiovascular system.

• Period of maximal vulnerability to teratogens (infection, hyperthermia, drugs, radiation, nicotine, narcotics).

• Clinical implications:

  • Necessity of healthy lifestyle before conception & during early pregnancy.

  • Many women are unaware of pregnancy during this critical window.

  • Insight into congenital anomaly mechanisms (e.g. cleft palate) & prenatal corrective strategies.

Week $3$: Key Events

Gastrulation

• Primitive streak (rapidly dividing epiblast mid-line) produces mesoderm between epiblast & hypoblast ➔ trilaminar disc.

• Primitive streak active through week $4$ then degenerates.

• Three germ layers & derivatives (see Fig. 18.20):

  • Ectoderm.

  • Mesoderm.

  • Endoderm.

Notochord Formation

• Midline mesodermal cord defines cranio-caudal axis, signals cell specialisation.

• Framework for axial skeleton & inducer of neural plate.

Somite Formation

• Paired mesodermal blocks lateral to notochord.

• $\approx 38$ pairs form $\text{days }20\text{–}30$; $42\text{–}44$ pairs by week $5$.

• Give rise to axial skeleton, associated muscle, dermis; visible elevations allow embryonic age determination.

Neurulation

• Notochord induces ectoderm thickening → neural plate.

• Neural folds elevate & fuse → neural tube (primordium of CNS).

• Incomplete closure ➔ neural tube defects (e.g. spina bifida).

Additional Week-3 Changes

• Early blood-vessel formation.

• Primitive uteroplacental circulation established by week’s end.

• Onset of organogenesis.

Cellular & Molecular Principles Guiding Development

• Growth: ↑ cell number & size.

• Differentiation: emergence of specialised cell types.

• Organisation: integration into functional units.

• Gene families switched on as early as the $2\text{–}4$-cell stage produce signalling proteins; environment modulates expression.

Fundamental Processes (after Blackburn $2013$)

1. Cell differentiation

   • Begins end week $1$ (inner cell mass vs. trophoblast).

   • Same genome; selective gene activation restricts/permits developmental pathways (≥ $350$ distinct adult cell types).

2. Induction

   • One tissue’s signals influence another (e.g. sequential inductions forebrain → optic cup → lens → cornea).

   • Blockade of any step halts subsequent structures.

3. Differential cell proliferation

   • Unequal growth rates shape structures (e.g. neural groove).

   • Teratogens or physical constraints (e.g. diaphragmatic hernia) can inhibit proliferation ➔ malformations.

4. Programmed cell death (apoptosis)

   • Hollow organ lumen formation; removal of digital webbing.

   • Inhibition ➔ syndactyly, atresias; excess ➔ micromelia.

5. Cell size/shape change

   • Microtubule chemistry drives elongation; toxins may disrupt.

   • Osmotic shifts cause swelling/shrinkage.

6. Cell migration

   • Lamellipodia attach ➔ contraction pulls cell.

   • Failure (e.g. neural crest migration) causes Hirschsprung’s disease.

7. Recognition & adhesion

   • Complementary surface molecules (e.g. neural fold fusion).

   • Disruption may underlie cleft palate, NTDs.

8. Folding of embryo

   • Transverse folding → cylindrical body; longitudinal folding → head & tail folds.

9. Differential maturity

   • Organs mature at varying rates (gut complete at birth vs. lungs/alveoli & long bones post-natally) — explains stage-specific toxin susceptibility.

Organogenesis Visual Highlights (weeks $4\text{–}8$)

Week $4$

• Straight embryo begins C-shape.

• Somite segmentation obvious.

• Neural tube closing with open rostral/caudal neuropores.

• Branchial arches (future face/neck) present.

• Forebrain prominence, limb buds (upper → lower), otic pits, tapered tail, beating heart.

Week $5$

• Brain/head enlarge rapidly; face contacts cardiac prominence.

• Upper-limb hand plates develop.

Week $6$

• Limb differentiation (elbow, wrist); digital rays in hand.

• External ear canal & pinna; pigmented eyes; partial neck/thorax straightening; head over-bent.

Week $7$

• Physiological umbilical herniation of mid-gut.

• Notches between hand plate rays, prominent liver.

Week $8$

• Hands: short webbed digits lengthen; feet show digital notches.

• Tail regresses; neck apparent; eyes open, eyelids forming; low-set auricles; external genitalia undifferentiated.

Critical-Period Concept (Fig. 18.22)

• Each organ system has a specific window of rapid morphogenesis when teratogenic exposure is most harmful.

Fetal Period (≈ $9$ weeks → birth)

• Characterised by growth & functional maturation.

• Head growth decelerates vs. body.

• Viability: $32\text{–}34$ w → independent survival; $22\text{–}26$ w possible with NICU (neurological risk ↑ < $24$ w).

• Surveys: clinicians ‘almost always’ resuscitate at $24$ w; non-tertiary staff often underestimate survival.

Folic Acid & Neural Tube Defects (NTDs)

• Increased pre-conception folic acid ↓ NTD incidence.

• Modelling (Bower $2006$): raising intake $0.1\,\text{mg}→0.2\,\text{mg}$ could prevent $49$ NTDs / year (Australia), $7$ among Aboriginal infants, $11$ in NZ ($95\%$ CI values provided).

• Post-mandatory fortification (AU $2016$): ↑ red-cell folate & ↓ NTDs in Aboriginal population.

• NZ opted for voluntary fortification (less effective).

• Emerging research: MTHFR enzyme mutations modify folate metabolism & unmetabolised folic acid levels.

• Global review (Gomes $2016$): $69.4\%$ of $39$ countries recommend healthy diet + $400\,\mu\text{g}\,/\text{d}$ folic acid pre-conception → $8\text{–}12$ w gestation (WHO-aligned).

Fetal Development Highlights (Table 18.3)

• Weeks $9\text{–}12$: Eyes close; external sex discernible by $12$ w; erythropoiesis shifts liver → spleen; urine enters amniotic fluid.

• Weeks $13\text{–}16$: Head proportionately smaller; skeletal ossification starts; ovaries with primordial follicles by $16$ w; eyes now anterior.

• Weeks $17\text{–}20$: Growth slows; limbs reach final proportion; quickening felt; brown fat forms; uterus complete ($18$ w); vaginal canal begins, testes start descent ($20$ w).

• Weeks $21\text{–}25$: Major weight gain; better body proportions; pulmonary surfactant production begins though lungs immature.

• Weeks $26\text{–}29$: Lungs capable of respiration; CNS can drive breathing; marrow assumes erythropoiesis by $28$ w; testes descent continues ($28\text{–}32$ w).

• Weeks $30\text{–}34$: Pupillary light reflex at $31$ w; white fat ≈ $8\%$ body weight.

• Weeks $35\text{–}38$: Firm grasp; head & abdominal circumferences equal at $36$ w; growth decelerates; white fat ≈ $16\%$ body weight.

Placenta & Fetal Membranes

• Placenta: fetomaternal organ from trophoblast; development starts week $2$; functionally established $8\text{–}10$ w; full size by month $4$.

  • Separates but connects maternal–fetal circulations (gas/nutrient exchange).

  • Hormone production (after trophoblast-secreted hCG sustains corpus luteum until $8\text{–}10$ w).

• Chorio-amniotic membrane: surrounds fetus & amniotic fluid; metabolically active, hormone-producing.

Uteroplacental & Fetoplacental Circulation

• Development of trophoblastic lacunae + embryonic vasculature enhances exchange efficiency beyond early cell-to-cell diffusion.

Clinical / Ethical / Practical Implications

• Understanding timing & mechanisms of development underpins:

  • Pre-conceptual counselling & lifestyle modifications.

  • Timing of prenatal screening/interventions.

  • Justification for folic acid supplementation & food fortification policies.

  • Interpretation of congenital anomaly aetiology & potential in-utero correction.

• Low birth weight correlates (Barker, Kajantie): adult risk ↑ for coronary heart disease, stroke, hypertension, type-II diabetes.